FLORITER. New Technology for Innovative Formulation Design.

Similar documents
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

The unlocked synergy of DFE Pharma MCC

SENTRY TM POLYOX Water Soluble Resins

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

The binding performance of DFE Pharma Starch

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Formulation and Evaluation

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

Easy, fast and reliable!

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

Content Uniformity of Direct Compression tablets

SCIENTIFIC DISCUSSION

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Adopting Technologies to Enhance Quality in Manufacturing

Technical brochure StarLac

Formulation and evaluation of oro-dispersible tablets of lafutidine

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

DRUG PRODUCT PERFORMANCE: CONSIDERATIONS FOR INTERCHANGEABILITY OF MULTISOURCE DRUG SUBSTANCES AND DRUG PRODUCTS

REVISION OF MONOGRAPH ON TABLETS. Tablets

3. Drug or plant or excipients profile

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Technical brochure CombiLac

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

SCIENTIFIC DISCUSSION

TABLET DESIGN AND FORMULATION

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

SCIENTIFIC DISCUSSION. Efavirenz

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

SPS Pharma: Who we are?

SCIENTIFIC DISCUSSION

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Office europeen des brevets. Publication number: Applicant: Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo(JP)

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

SCIENTIFIC DISCUSSION

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

SCIENTIFIC DISCUSSION

STARCH Application Data

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

Solving the solubility challenge: A key success factor of pharmaceutical formulations

Effect of Compaction Forces on Powder Bed Permeability of Magnesium Silicate "Common Excipient Mixture"

STANDARD FOR A BLEND OF SKIMMED MILK AND VEGETABLE FAT IN POWDERED FORM CODEX STAN Adopted in Amendment: 2010, 2013, 2014, 2016.

SCIENTIFIC DISCUSSION. AkuriT-3 Tablets*

B for hydrogen sulfide removal (e.g. in oil exploration) B highly active zinc compound B excellent cost/performance ratio

Journal of Chemical and Pharmaceutical Research

METOLOSE: CONTENTS PAGE

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

SCIENTIFIC DISCUSSION

Easy, fast and reliable!

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

21 st Century Challenges in Fertilizer Coatings

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

LAB.2. Tablet Production Methods

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

The Particle Design of Cellulose and the Other Excipients for a Directly Compressible Filler-Binder

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Re-compaction properties of lactose and microcrystalline cellulose

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Etat des travaux du GDP

The Wright Grou. the history of

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

CODEX STANDARD FOR MILK POWDERS AND CREAM POWDER

Sivakasi , Tamil Nadu, India. ABSTRACT KEYWORDS:

US A United States Patent (19) 11 Patent Number: 5,635,209 Groenewoud et al. 45 Date of Patent: Jun. 3, 1997

Solid and sterile finished dosage forms. Delivered.

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

African Journal of Pharmaceutical Research & Development

STANDARD FOR MILK POWDERS AND CREAM POWDER CODEX STAN

what is Fibersol-2 AG?

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Challenges and solutions for moisture sensitive API formulation

Available online through

SCIENTIFIC DISCUSSION. Darunavir

Rationale of and Experience with the Expert System

Designed and manufactured specifically for pharmaceutical capsule filling

Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate

Formulation and evaluation of immediate release salbutamol sulphate

LECTURE 10. PACKAGING TECHNOLOGY

Transcription:

FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp

FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent compressibility. FLORITE offers many advantages for various applications such as pharmaceutical, food, cosmetic and other industrial use. FLORITE has a unique petaloid crystal structure, and deep and large macropores that show remarkably large pore size and volume, which are different from conventional porous materials. These macropores provide you relatively extensive options in controlling a specific performance for capturing, carrying, releasing and reacting to various substances. FLORITE is a multifunctional excipient, which can be used as an API stabilizer and extended release carrier, in addition to use as an excellent liquid carrier and binder. Advantages of FLORITE Liquid Absorbency; Absorb fivefold amount liquid of own weight for alteration to powder-form Compressibility; Boost a tablet hardness in the tableting Stabilizing Capability; Protect loading API in the macropore from light and oxygen Release Control; Extend the dissolution rate of loading API in the macropore by combination use with other excipients Solid Dispersion; Improve the release property of poorly-water soluble API in the macropore by amorphization Ready to Use; Conforms to USP-NF, EU E-No., JECFA GSFA, and other standards for pharmaceutical excipient and food additive Product Line Up Product FLORITE R FLORITE PS-10 FLORITE PS-200 FLORITE RT Appearance White powder White fine powder White fine granule White powder Oil Absorption (ml/g) Loose Bulk Density (g/ml) Tapped Bulk Density (g/ml) Average Particle Size (µm) 4.6 3.2 3.7 4.2 0.07 0.08 0.07 0.09 0.10 0.12 0.09 0.11 30 10 150 30 Use Pharmaceuticals, Foods, Cosmetics, Chemicals Pharmaceuticals, Foods, Cosmetics Pharmaceuticals Chemicals Feature Multi-Purpose Fine Powder Fine Granule Lubricant Premixed 1

Liquid Absorbency Unlike the pore structure of any general porous material, the unique petaloid crystal structure of FLORITE forms macropores which have large volume, in the particle. These macropores are the key factor for absorbing capacity. FLORITE can absorb and retain liquid, which amount is approximately fivefold compared with its own weight. The macropores develop deeply in the vertical direction, and thus the openings of these pores have small areas compared to their volumes, which has the effect of protecting the liquid filled in the pores from being affected by oxygen, vapor, or other elements in the external environment. Deep and Large volume macropores from unique petaloid crystal structure Capacity to Absorb Five Times its own weight in liquid Oil absorption (ml/g) 5.0 4.0 3.0 2.0 1.0 4.6 2.5 1.1 Oil Absorbing capacity of FLORITE in comparison with other materials 0.5 0.3 0.2 0 FLORITE Silicon Dioxide Microcrystalline Cellulose Mica Sericite Talc Changes of pore size distribution of FLORITE R in the case of absorbing half to two times fish oil of own weight Macropore Space is contributed to absorb and retain liquid. X 2.0 X 1.0 X 0.5 Blank Changes of pore size distribution of FLORITE PS-10 in the case of absorbing half to two times fish oil of own weight X 0.5 Blank X 1.0 X 2.0 2

Liquid Carrying Application ; Fish Oil Powderization For pharma and food applications, FLORITE offers the powderization of oily ingredients. A fish oil derived from tuna and bonito was absorbed into FLORITE to make a powder. A mixture of 100 g of FLORITE with 100 g of the fish oil, was agitated, to obtain fish oil powders with respective liquid absorbing ratios of 1:1. Separately, silicon dioxide, was used, and the same procedure was followed to obtain a fish oil powder with a liquid absorbing ratio of 1:1 as a reference. Thirty grams of the fish oil powder was weighed and introduced into a polyethylene bag, after which the bag was sealed and stored in a chamber controlled at 40 C and 75% RH, to measure the changes in the peroxide value (PV) and evaluate the oxidization stability. The PV of the fish oil powder prepared with silicon dioxide began rising sharply in an initial stage of storage, and increased sixfold by day 7 compared to the level at the beginning of storage. On the other hand, the fish oil powders prepared from FLORITE showed gradual PV changes throughout the storage period, where the PVs remained virtually unchanged until day 14 of storage, despite the absence of the antioxidant in these powders. Peroxide Value (meq/kg) Changes of peroxide value on fish oil powder Oxidization Stability is improved because the fish oil in the macropores was prevented from easily contacting the outside air. : FLORITE R, : FLORITE PS-10, : Silicon Dioxide The fish oil powder was mixed with granulated lactose as an excipient, and also with a calcium stearate as a lubricant, and the mixture was compressed into tablets. The hardness of the obtained tablets was measured, and as indicators of tableting producibility, the incidence of leakage of fish oil from the tablets, and the incidence of lamination, were also evaluated. Superior Compressibility without any leakage is exhibited under tableting process Tablet hardness and appearance of fish oil powder Leakage and Lamination Incidents of fish oil tablet : Leakage, : Lamination The FLORITE R tablets were the whitest, and the FLORITE PS-10 tablets had slight fish oil color. On the other hand, the silicon dioxide tablets had mottle appearance on the tablet surface, caused by leakage of fish oil at the time of tableting. In terms of their hardness, the FLORITE PS-10 tablets were the hardest, followed by the FLORITE R tablets that demonstrated sufficient hardness. However, the silicon dioxide tablets were very brittle. While the silicon dioxide allowed the fish oil to leak out and laminate considerably at the time of tableting, no such leakage occurred in FLORITE, with FLORITE R showing some lamination, and FLORITE PS-10 remaining lamination-free. 3

Liquid Carrying Application ; Flavor Stabilization For food applications, FLORITE offers the stabilization of flavor and fragrance. Orange essential oil was absorbed into FLORITE to enhance long-term flavor intensity. A mixture of 8.0 g of FLORITE with 12.0 g of the orange essential oil, was agitated, to obtain orange oil powder, and commercial orange flavor powder was used as a reference. One gram of the orange oil powder was weighed and introduced into a polyethylene bag, after which the bag was sealed and stored in a chamber controlled at 40 C and 75% RH, to measure the changes in the flavor intensity and quality, by sensory inspection. Scoring table for the sensory inspection Score 1 2 3 4 5 6 Flavor intensity unscented almost unscented slightly scented scented very scented strongly scented Flavor quality strongly very slightly no good Lasting Effect For Flavor is exhibited because the orange oil in the macropores was prevented from oxidization, and gradually released. Changes of flavor intensity Changes of flavor quality Commercial Powder Commercial Powder The orange oil powder prepared from FLORITE showed gradual the Intensity and quality changes as compared to the commercial powder. 4

Compressibility In the compression process, the crystal structure of FLORITE is easily to broken at low pressure, and each petaloid structure binds together strongly to exhibit superior binding capability. It can achieve to the necessary hardness with minimal pressure, by adding FLORITE to your formulation. Powerful Binding Performance is exhibited at even low compression force and it reaches the preferred tablet hardness with less than half the compression force of the other binder. The formulation for tableting study Compressibility of FLORITE in comparison with other binders Ram material Acetaminophen Binder FLORITE R FLORITE PS-200 Granulated Lactose Microcrystalline Cellulose Dibasic Calcium Phosphate, Anhydrous Crosspovidone Magnesium Stearate Total Assay 22.6 mg 90.2 mg 6.6 mg 0.6 mg 120 mg Solid Dosage Form Applications; Metformin Tablet Metformin hydrochloride is a high daily dose pharmaceutical for type 2 diabetes. The higher content tablet is much more convenient for the patients. FLORITE offers the high Metformin content tablet by direct compression as easy way. A mixture of Metformin hydrochloride with silicon dioxide, was blended with FLORITE PS-200, Microcrystalline cellulose, Crosspovidone and Magnesium stearate, as indicated in the below table, to obtain a mixture for the tableting study. Separately, a mixture without FLORITE was blended to obtain a reference. The mixtures were compressed into tablets, and the hardness, the disintegration time and the dissolution rate of the obtained tablets were measured. High Metformin Content Tablet can be produced at lower compression force. The formulation for Metformin tablet Raw material Reference FLORITE PS-200 Metformin HCl 223.1 mg 223.1 mg Fluidizing agent Silicon dioxide Binder FLORITE PS-200 Microcrystalline Cellulose 1.8 mg 1.8 mg 123.2 mg 11.6 mg 111.6 mg Crosspovidone 7.7 mg 7.1 mg Magnesium Stearate 1.8 mg 1.8 mg Total 357 mg 357 mg Tablet hardness of Metformin tablet 5

Quick Disintegrate and Release Tablet is obtained with harder tablets. Metformin tablet disintegration time Metformin tablet dissolution time of 10 kn as compression force Although FLORITE PS-200 tablets were harder, they demonstrated quick disintegration time compared with the reference tablets. Regarding dissolution time, FLORITE exhibited a rapid dissolution rate, which was the same as the reference tablet. Package and Material Information Products FLORITE R FLORITE PS-10 FLORITE PS-200 FLORITE RT Chemical Name Calcium Silicate CAS Number 1344-95-2 EINECS Number 215-710-8 US TSCA Number 1344-95-2 Korea ECL Number KE-30983 Compendial Status NF/JPE/JSQI NF NF DMF Status US:28644 Type IV INS Number 552 552 552 EU E Number 552 552 552 Standard Container Polyethylene bag with multi-layered polyester inner bag Paper bag with polyethylene inner bag Polyethylene bag with multi-layered polyester inner bag Paper bag Standard Package 5 kg 5 kg 5 kg 10 kg *JSQI : Japanese Standards of Quasi-drug Ingredients Recommended Application Powderization and Carrier of Vitamins Powderization and Carrier of Essential Oils Powderization and Carrier of Fragrances and Flavors Powderization and Carrier of Liquid APIs Solubility Improvement of Poorly-Soluble APIs Producibility Improvement in Compression Process Binder for Various Solid-Form Applications 6

Contact Us: www.tomitaph.co.jp/english Tokyo Branch Osaka Branch New Jersey Branch 2-4-3, Iwamoto-cho, Chiyoda-ku, Tokyo 101-0032, Japan Phone: +81-3-3851-7051 Fax: +81-3-3851-7052 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan Phone: +81-6-6229-3800 Fax: +81-6-6229-3801 2 Executive Drive, Suite 435, Fort Lee, NJ07024, USA Phone: +1-201-944-3904 Fax: +1-201-944-3908 2018/04/Ver.2.0